AKT1 and pancreatic neoplasm: In addition, PRCP KD decreased levels of activated (S473 phosphorylated) AKT in both cell lines (Figure 2C,F), consistent with our previous report that PRCP knockdown reduces activated AKT levels in pancreatic cancer cells [24].